Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 15;98(2):482–489. doi: 10.1172/JCI118815

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

J McLaren 1, A Prentice 1, D S Charnock-Jones 1, S A Millican 1, K H Müller 1, A M Sharkey 1, S K Smith 1
PMCID: PMC507453  PMID: 8755660

Abstract

Angiogenesis is important in the pathophysiology of endometriosis, a condition characterized by implantation of ectopic endometrium in the peritoneal cavity. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor involved in physiological and pathological angiogenesis, and elevated levels of VEGF are found in peritoneal fluid of patients with endometriosis. Our aim was to investigate the site of expression and regulation of VEGF in endometriosis. VEGF immunoreactivity was found in tissue macrophages present in ectopic endometrium and in activated peritoneal fluid macrophages. Macrophage activation was highest in women with endometriosis, and media conditioned by peritoneal fluid macrophages from these women caused a VEGF-dependent increase in endothelial cell proliferation above that seen from normal women. Peritoneal fluid macrophages secreted VEGF in response to ovarian steroids, and this secretion was enhanced after activation with lipopolysaccharide. Peritoneal fluid macrophages expressed receptors for steroid hormones. VEGF receptors flt and KDR (kinase domain receptor) were also detected, suggesting autocrine regulation. During the menstrual cycle, expression of flt was constant but that of KDR was increased in the luteal phase, at which time the cells migrated in response to VEGF. KDR expression and the migratory response were significantly higher in patients with endometriosis. This study demonstrates that activated macrophages are a major source of VEGF in endometriosis and that this expression is regulated directly by ovarian steroids.

Full Text

The Full Text of this article is available as a PDF (436.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995 Oct;1(10):1024–1028. doi: 10.1038/nm1095-1024. [DOI] [PubMed] [Google Scholar]
  2. Berse B., Brown L. F., Van de Water L., Dvorak H. F., Senger D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992 Feb;3(2):211–220. doi: 10.1091/mbc.3.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boocock C. A., Charnock-Jones D. S., Sharkey A. M., McLaren J., Barker P. J., Wright K. A., Twentyman P. R., Smith S. K. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst. 1995 Apr 5;87(7):506–516. doi: 10.1093/jnci/87.7.506. [DOI] [PubMed] [Google Scholar]
  4. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992 Feb;114(2):521–532. doi: 10.1242/dev.114.2.521. [DOI] [PubMed] [Google Scholar]
  5. Chao T. C., Van Alten P. J., Greager J. A., Walter R. J. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol. 1995 Jan;160(1):43–49. doi: 10.1016/0008-8749(95)80007-6. [DOI] [PubMed] [Google Scholar]
  6. Charnock-Jones D. S., Sharkey A. M., Boocock C. A., Ahmed A., Plevin R., Ferrara N., Smith S. K. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod. 1994 Sep;51(3):524–530. doi: 10.1095/biolreprod51.3.524. [DOI] [PubMed] [Google Scholar]
  7. Charnock-Jones D. S., Sharkey A. M., Rajput-Williams J., Burch D., Schofield J. P., Fountain S. A., Boocock C. A., Smith S. K. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993 May;48(5):1120–1128. doi: 10.1095/biolreprod48.5.1120. [DOI] [PubMed] [Google Scholar]
  8. De Leon F. D., Vijayakumar R., Brown M., Rao C. V., Yussman M. A., Schultz G. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol. 1986 Aug;68(2):189–194. [PubMed] [Google Scholar]
  9. Eischen A., Duclos B., Schmitt-Goguel M., Rouyer N., Bergerat J. P., Hummel M., Oskam R., Oberling F. Human resident peritoneal macrophages: phenotype and biology. Br J Haematol. 1994 Dec;88(4):712–722. doi: 10.1111/j.1365-2141.1994.tb05109.x. [DOI] [PubMed] [Google Scholar]
  10. Ferrara N., Henzel W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989 Jun 15;161(2):851–858. doi: 10.1016/0006-291x(89)92678-8. [DOI] [PubMed] [Google Scholar]
  11. Ferrara N., Houck K., Jakeman L., Leung D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992 Feb;13(1):18–32. doi: 10.1210/edrv-13-1-18. [DOI] [PubMed] [Google Scholar]
  12. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. doi: 10.1126/science.2432664. [DOI] [PubMed] [Google Scholar]
  13. Frazier-Jessen M. R., Kovacs E. J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol. 1995 Feb 15;154(4):1838–1845. [PubMed] [Google Scholar]
  14. Gitay-Goren H., Halaban R., Neufeld G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun. 1993 Feb 15;190(3):702–708. doi: 10.1006/bbrc.1993.1106. [DOI] [PubMed] [Google Scholar]
  15. Greene G. L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986 Mar 7;231(4742):1150–1154. doi: 10.1126/science.3753802. [DOI] [PubMed] [Google Scholar]
  16. Halme J., Becker S., Hammond M. G., Raj M. H., Raj S. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol. 1983 Feb 1;145(3):333–337. doi: 10.1016/0002-9378(83)90720-2. [DOI] [PubMed] [Google Scholar]
  17. Halme J., Becker S., Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol. 1987 Apr;156(4):783–789. doi: 10.1016/0002-9378(87)90333-4. [DOI] [PubMed] [Google Scholar]
  18. Halme J. Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro. Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1718–1725. doi: 10.1016/0002-9378(89)90957-5. [DOI] [PubMed] [Google Scholar]
  19. Houck K. A., Ferrara N., Winer J., Cachianes G., Li B., Leung D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991 Dec;5(12):1806–1814. doi: 10.1210/mend-5-12-1806. [DOI] [PubMed] [Google Scholar]
  20. Hu S. K., Mitcho Y. L., Rath N. C. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol. 1988;10(3):247–252. doi: 10.1016/0192-0561(88)90055-0. [DOI] [PubMed] [Google Scholar]
  21. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jakeman L. B., Winer J., Bennett G. L., Altar C. A., Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest. 1992 Jan;89(1):244–253. doi: 10.1172/JCI115568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Keenan J. A., Chen T. T., Chadwell N. L., Torry D. S., Caudle M. R. Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol. 1994 Oct;32(3):180–183. doi: 10.1111/j.1600-0897.1994.tb01111.x. [DOI] [PubMed] [Google Scholar]
  24. Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr 29;362(6423):841–844. doi: 10.1038/362841a0. [DOI] [PubMed] [Google Scholar]
  25. Koch A. E., Harlow L. A., Haines G. K., Amento E. P., Unemori E. N., Wong W. L., Pope R. M., Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994 Apr 15;152(8):4149–4156. [PubMed] [Google Scholar]
  26. Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989 Dec 8;246(4935):1306–1309. doi: 10.1126/science.2479986. [DOI] [PubMed] [Google Scholar]
  27. Li X. F., Gregory J., Ahmed A. Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors. 1994;11(4):277–282. doi: 10.3109/08977199409011000. [DOI] [PubMed] [Google Scholar]
  28. McLaren J., Prentice A., Charnock-Jones D. S., Smith S. K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 1996 Jan;11(1):220–223. doi: 10.1093/oxfordjournals.humrep.a019023. [DOI] [PubMed] [Google Scholar]
  29. Misrahi M., Atger M., d'Auriol L., Loosfelt H., Meriel C., Fridlansky F., Guiochon-Mantel A., Galibert F., Milgrom E. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun. 1987 Mar 13;143(2):740–748. doi: 10.1016/0006-291x(87)91416-1. [DOI] [PubMed] [Google Scholar]
  30. Nisolle M., Casanas-Roux F., Anaf V., Mine J. M., Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril. 1993 Mar;59(3):681–684. [PubMed] [Google Scholar]
  31. Oosterlynck D. J., Meuleman C., Sobis H., Vandeputte M., Koninckx P. R. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril. 1993 Apr;59(4):778–782. doi: 10.1016/s0015-0282(16)55859-2. [DOI] [PubMed] [Google Scholar]
  32. Pepper M. S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 1991 Dec 16;181(2):902–906. doi: 10.1016/0006-291x(91)91276-i. [DOI] [PubMed] [Google Scholar]
  33. Phillips G. D., Stone A. M., Jones B. D., Schultz J. C., Whitehead R. A., Knighton D. R. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo. 1994 Nov-Dec;8(6):961–965. [PubMed] [Google Scholar]
  34. Polan M. L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., Bottomly K. Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab. 1989 Dec;69(6):1200–1206. doi: 10.1210/jcem-69-6-1200. [DOI] [PubMed] [Google Scholar]
  35. Pötgens A. J., Lubsen N. H., van Altena M. C., Schoenmakers J. G., Ruiter D. J., de Waal R. M. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol. 1995 Jan;146(1):197–209. [PMC free article] [PubMed] [Google Scholar]
  36. Ravindranath N., Little-Ihrig L., Phillips H. S., Ferrara N., Zeleznik A. J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology. 1992 Jul;131(1):254–260. doi: 10.1210/endo.131.1.1612003. [DOI] [PubMed] [Google Scholar]
  37. Rier S. E., Parsons A. K., Becker J. L. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril. 1994 Feb;61(2):294–299. doi: 10.1016/s0015-0282(16)56520-0. [DOI] [PubMed] [Google Scholar]
  38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  39. Ryan I. P., Tseng J. F., Schriock E. D., Khorram O., Landers D. V., Taylor R. N. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril. 1995 Apr;63(4):929–932. [PubMed] [Google Scholar]
  40. Senger D. R., Van de Water L., Brown L. F., Nagy J. A., Yeo K. T., Yeo T. K., Berse B., Jackman R. W., Dvorak A. M., Dvorak H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993 Sep;12(3-4):303–324. doi: 10.1007/BF00665960. [DOI] [PubMed] [Google Scholar]
  41. Sharkey A. M., Charnock-Jones D. S., Boocock C. A., Brown K. D., Smith S. K. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil. 1993 Nov;99(2):609–615. doi: 10.1530/jrf.0.0990609. [DOI] [PubMed] [Google Scholar]
  42. Shen H., Clauss M., Ryan J., Schmidt A. M., Tijburg P., Borden L., Connolly D., Stern D., Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood. 1993 May 15;81(10):2767–2773. [PubMed] [Google Scholar]
  43. Simoni J., Simoni G., Lox C. D., McGunegle D. E., Feola M. Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):525–534. doi: 10.3109/10731199409117880. [DOI] [PubMed] [Google Scholar]
  44. Strathy J. H., Molgaard C. A., Coulam C. B., Melton L. J., 3rd Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril. 1982 Dec;38(6):667–672. doi: 10.1016/s0015-0282(16)46691-4. [DOI] [PubMed] [Google Scholar]
  45. Terman B. I., Dougher-Vermazen M., Carrion M. E., Dimitrov D., Armellino D. C., Gospodarowicz D., Böhlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579–1586. doi: 10.1016/0006-291x(92)90483-2. [DOI] [PubMed] [Google Scholar]
  46. Unemori E. N., Ferrara N., Bauer E. A., Amento E. P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992 Dec;153(3):557–562. doi: 10.1002/jcp.1041530317. [DOI] [PubMed] [Google Scholar]
  47. Wilting J., Christ B., Bokeloh M., Weich H. A. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 1993 Oct;274(1):163–172. doi: 10.1007/BF00327997. [DOI] [PubMed] [Google Scholar]
  48. de Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992 Feb 21;255(5047):989–991. doi: 10.1126/science.1312256. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES